C12Y 305/03011
Agmatinase
Official title: Agmatinase (3.5.3.11)
C12Y305/03011 (Agmatinase) appears on 5 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 10
- Assignees
- 6
- Inventors
- 13
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 4 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 3 | 0 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Tropane alkaloid (TA) producing non-plant host cells, and methods of making and using the same25 Nov 2025US 12,480,131 B2The Board of Trustees of the Leland Stanford Junior University
- Guanidine degradation enzyme and methods of use21 Oct 2025US 12,448,632 B2Alliance for Sustainable Energy, LLC
- Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system26 Aug 2025US 12,397,022 B2Holobiome, Inc.
- Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system14 Sep 2021US 11,116,804 B2Holobiome, Inc.
- Biochemical synthesis of 1,4-butanediamine20 Dec 2016US 9,523,083 B2Dsm IP Assets B.V.
- Tropane Alkaloid (TA) Producing Non-Plant Host Cells, and Methods of Making and Using the Same17 Sep 2026US 2026/0275357 A1The Board of Trustees of the Leland Stanford Junior University
- Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system1 Jan 2026US 2026/0000717 A1Holobiome, Inc.
- Tropane Alkaloid Transporters and Methods of Making Tropane Alkaloids Using the Same13 Jun 2024US 2024/0191267 A1The Board of Trustees of the Leland Stanford Junior University
- Promoter for the specific expression of genes in agmat-positive cells in layer 2/3 of mouse cortex29 Dec 2022US 2022/0411789 A1Friedrich Miescher Institute for Biomedical Research
- Guanidine degradation enzyme and methods of use30 Jun 2022US 2022/0204998 A1Alliance for Sustainable Energy, LLC
Most cited
By later US patents